Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections: Report of a Case Series

Spiridon Papapetropoulos, Carlos Singer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.

Original languageEnglish
Pages (from-to)364-367
Number of pages4
JournalClinical Neuropharmacology
Volume29
Issue number6
DOIs
StatePublished - Nov 1 2006

Fingerprint

Botulinum Toxins
Tremor
Injections
Trihexyphenidyl
Type A Botulinum Toxins
Therapeutics
Signs and Symptoms

Keywords

  • Botulinum toxin type A
  • Case series
  • Clinical characteristics
  • Dystonia
  • Primary writing tremor
  • Treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections : Report of a Case Series. / Papapetropoulos, Spiridon; Singer, Carlos.

In: Clinical Neuropharmacology, Vol. 29, No. 6, 01.11.2006, p. 364-367.

Research output: Contribution to journalArticle

@article{c23d1981eed74be7a27c29207fad10b6,
title = "Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections: Report of a Case Series",
abstract = "Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.",
keywords = "Botulinum toxin type A, Case series, Clinical characteristics, Dystonia, Primary writing tremor, Treatment",
author = "Spiridon Papapetropoulos and Carlos Singer",
year = "2006",
month = "11",
day = "1",
doi = "10.1097/01.WNF.0000236765.00785.9C",
language = "English",
volume = "29",
pages = "364--367",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections

T2 - Report of a Case Series

AU - Papapetropoulos, Spiridon

AU - Singer, Carlos

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.

AB - Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.

KW - Botulinum toxin type A

KW - Case series

KW - Clinical characteristics

KW - Dystonia

KW - Primary writing tremor

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33750898278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750898278&partnerID=8YFLogxK

U2 - 10.1097/01.WNF.0000236765.00785.9C

DO - 10.1097/01.WNF.0000236765.00785.9C

M3 - Article

C2 - 17095901

AN - SCOPUS:33750898278

VL - 29

SP - 364

EP - 367

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 6

ER -